Does adding intraperitoneal paclitaxel to standard intraperitoneal regimen yield incremental survival? A propensity score-matched cohort study

We recruited consecutive patients with stage III epithelial ovarian, tubal, and peritoneal cancers who had optimal residual tumor after primary cytoreductive surgery and who received intraperitoneal chemotherapy between 2002 and 2012. Two propensity score-matched sample cohorts were created. We foun...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Chin J Cancer
Egile Nagusiak: Chang, Yen-Hou, Lu, Chien-Hsing, Yen, Ming-Shyen, Lee, Wai-Hou, Chang, Yi, Chang, Wei-Pin, Chuang, Chi-Mu
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2016
Gaiak:
Letter to the Editor
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4862156/
https://ncbi.nlm.nih.gov/pubmed/27160669
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-016-0105-3
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak